Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;134(8):e464.
doi: 10.1016/j.amjmed.2021.02.023.

The Reply

Peter A McCullough  1
Affiliations
Comment

The Reply

Peter A McCullough. Am J Med. 2021 Aug.
No abstract available

PubMed Disclaimer

Comment on

  • Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.
    McCullough PA, Kelly RJ, Ruocco G, Lerma E, Tumlin J, Wheelan KR, Katz N, Lepor NE, Vijay K, Carter H, Singh B, McCullough SP, Bhambi BK, Palazzuoli A, De Ferrari GM, Milligan GP, Safder T, Tecson KM, Wang DD, McKinnon JE, O'Neill WW, Zervos M, Risch HA. McCullough PA, et al. Am J Med. 2021 Jan;134(1):16-22. doi: 10.1016/j.amjmed.2020.07.003. Epub 2020 Aug 7. Am J Med. 2021. PMID: 32771461 Free PMC article. Review.
  • Clinical Omissions in COVID-19.
    Quinn MJ. Quinn MJ. Am J Med. 2021 Aug;134(8):e463. doi: 10.1016/j.amjmed.2021.01.036. Am J Med. 2021. PMID: 34340751 Free PMC article. No abstract available.

References

    1. McCullough PA, Oskoui R. Early multidrug regimens in new potentially fatal medical problems. Rev Cardiovasc Med. 2020;21(4):507–508. - PubMed
    1. McCullough PA, Kelly RJ, Ruocco G, et al. Pathophysiological basis and rationale for early outpatient treatment of SARS-CoV-2 (COVID-19) infection. Am J Med. 2021;134(1):16–22. - PMC - PubMed
    1. Derwand R, Scholz M, Zelenko V. COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study. Int J Antimicrob Agents. 2020;56(6):106214. - PMC - PubMed
    1. Procter BC, Ross C, Pickard V, Smith E, Hanson C, McCullough PA. Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection. Rev Cardiovasc Med. 2020;21(4):611–614. - PubMed
    1. Procter BC, Ross C, Pickard V, Smith E, Hanson C, McCullough PA. Early ambulatory multidrug therapy reduces hospitalization and death in high-risk patients with SARS-CoV-2 (COVID-19) Authorea. January 07, 2021 doi: 10.22541/au.161000355.54720791/v1. - DOI